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of >60°C (Figure, panel E). Thus, virus-contaminated ma-
terials such as surgical instruments can be decontaminated 
by heat. We also found that Zika virus infectivity was high-
est after adjusting the stock to a pH of ≈9 (Figure, panel 
F). In contrast, adjusting Zika virus to pH 12 or to <pH 4 
abrogated infectivity (Figure, panel F).
Finally, we analyzed whether gloves routinely used in 
BSL-2 laboratories protect against Zika virus. For this, we 
cut off fingertips of nitrile and latex gloves, filled tips with 
a Zika virus suspension, and placed them into cell culture 
plates containing medium. Virus-containing fingertips were 
inserted in such a way that diffusion would only occur if the 
virus passed through the nitrile/latex barrier. As a control, 
we made a hole of <1 mm in the fingertips. All 3 tested 
gloves prevented virus diffusion (Figure, panel G). How-
ever, if glove integrity was disrupted by a pin, the virus 
passed through in 2 of 3 cases (Figure, panel G).
We demonstrated that Zika virus is destroyed by clas-
sical disinfectants and inactivation methods and that nitrile 
and latex gloves are protective. We also showed that UV 
light of a laminar flow hood inactivates Zika virus, but 
particularly if the virus is in a protein-rich environment, 
the exposure time range should be in hours rather than in 
minutes. Although we expected that Zika virus would be 
inactivated by alcohol and disinfectants, we conducted a 
thorough experimental verification to exclude uncertainties 
surrounding work with this emerging pathogen.
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To the Editor: Klebsiella pneumoniae is mainly re-
sponsible for hospital-acquired urinary tract infections, 
bacteremia, pneumonia and intra-abdominal infections. 
However, since the mid-1980s, K. pneumoniae has also 
been described as the cause of highly invasive community-
acquired infections (1,2). The K. pneumoniae isolates as-
sociated with such infections are often hypermucoviscous 
and frequently belong to the capsular serotypes K1 or K2. 
Two of the most extensively studied genes associated with 
invasive infections are a mucoviscosity-associated gene 
A (magA) in serotype K1 and a regulator of mucoid phe-
notype A (rmpA). These strains of hypervirulent K. pneu-
moniae (hvKP) are now circulating worldwide (1,2).
At the same time, a substantial increase of high-level 
antimicrobial resistance acquired by non-hvKP strains has 
also been observed. Clonal complexes of hvKP and multi-
drug-resistant (MDR) strains had been considered indepen-
dent (3) until 2014, when extended-spectrum β-lactamase 
(ESBL)– or carbapenemase-producing hvKP were first 
identified in China (4). Here we report an ESBL-producing 
strain of hvKP isolated from a patient in France.
The patient was a 56-year-old woman, born in Algeria, 
who alternately resided in France and Algeria for several 
years without travel to any other country. She underwent liv-
er transplant in 2007 for primary biliary cirrhosis. In 2012, 
she had a routine posttransplant liver biopsy indicating 
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granulomatosis, resulting in several examinations to deter-
mine its etiology. The patient was afebrile with no inflam-
matory syndrome. A thoracic computed tomography scan 
indicated no abnormalities. We performed a bronchoalveolar 
lavage, and bacteriologic examination of the specimen indi-
cated a strain of K. pneumoniae with a hypermucoviscosity 
phenotype. We identified the ESBL phenotype with a posi-
tive double-disk synergy test between clavulanic acid and 
third-generation cephalosporins and aztreonam. We con-
ducted antimicrobial susceptibility tests according to guide-
lines issued in 2013 by the Comité de l’Antibiogramme de la 
Société Française de Microbiologie (http://www.sfm-micro-
biologie.org/UserFiles/files/casfm/CASFM2013vjuin.pdf). 
These tests revealed high-level resistance to third-genera-
tion cephalosporins and to all aminoglycosides except ami-
kacin. The strain was susceptible to cefoxitin, piperacillin/
tazobactam, carbapenems, all fluoroquinolones, fosfomycin, 
and trimethoprim/sulfamethoxazole. The patient did not re-
ceive any antimicrobial drug treatment and after 3 years of 
follow-up reported no signs of pneumopathy.
Multiplex PCR and sequencing of the identified strain 
indicated the presence of blaCTX-M-3 (5). We extracted plasmid 
carrying the ESBL gene with the DNA Plasmid Miniprep Kit 
(QIAGEN, Valencia, CA, USA) and transferred the gene by 
electroporation into Escherichia coli DH10B cells. Relaxase 
typing, which detects major replicon groups, revealed only 
IncL/M plasmid (6). We performed another multiplex PCR 
to determine capsular serotypes K1 or K2 and the presence 
of major virulence factors. The capsular serotype was K2 
(7). We identified rmpA, the plasmid-mediated gene regulat-
ing extracellular polysaccharide synthesis, and iutA, entB, 
mrkD, and ybtS genes by this PCR test. The isolate belonged 
to sequence type (ST) 86 as determined by multilocus se-
quence typing (http://www.pasteur.fr/mlst).
The earliest-described strains of hvKP, which were isolat-
ed from liver abscesses, were predominantly serotype K1 and 
ST23 (2). The most frequently isolated non-K1 hvKP stains 
are currently serotype K2, known to cause hepatic abscesses 
and severe cases of pneumonia and other hvKP-associated 
infections such as necrotizing fasciitis (2). The K2 strains iso-
lated to date appear to originate from a much broader range 
of ST groups that include ST86 and many others (e.g., ST65, 
ST66, ST373, ST374, ST375, ST380, and ST434) (8,9).
This patient, despite being immunocompromised, was 
only colonized with what is normally considered a highly 
pathogenic strain. In general, the acquisition of antimicro-
bial resistance genes reduces fitness, which could have 
been the case in this patient. However, other strains carry-
ing MDR and high-virulence genes, namely E. coli ST131, 
have no loss in fitness (10). These clones might harbor 
other biologic factors providing a competitive advantage.
MDR strains of K. pneumoniae have emerged in recent 
years and have been identified as a major threat to public 
health by the US Centers for Disease Control and Preven-
tion. hvKP, with its high pathogenic potential, has also been 
on the rise during the same period. In the past, MDR and 
hvKP strains evolved separately in distinct clonal groups 
(2), but the recent emergence of hvKP harboring the gene 
for MDR, such as the one identified in our study, raises new-
found concerns. Our patient was colonized with an ST86 
CTX-M-3–producing strain of K2 hvKP, raising the question 
of whether MDR hvKP strains could circulate in Europe.
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